Scope and Purpose

This workshop will provide a forum for scientists, regulatory authorities, ophthalmologists and transfusion experts on the usage, quality, clinical need and manufacture of eye drops from human origin. Selected scientific lectures from well-known experts will be presented. Key discussions to find commonalities in production and quality issues include the latest scientific knowledge. The aim is to reach consensus on classification, validation and standardization of these products. The active participation from various regulatory agencies will also be an important emphasis of this workshop.

Ample time shall be provided for a highly stimulating personal discussion:

  • To exchange knowledge between eye specialists, transfusion specialists and regulators
  • To enhance knowledge of eye physicians on properties of EDHO and its regulatory requirements
  • To enhance knowledge of transfusion specialists on serum eye drops, the clinical need, patient´s needs
  • To develop a common ground for the regulation of EDHO

Who should attend?

Don't miss this event if you belong to one of these groups: 

  • Regulatory authorities
  • Manufacturers of EDHO
  • Blood establishments
  • Transfusion medicine specialists
  • Ophthalmologists
  • Researchers
  • Vendors

Participation fee and Capacity

The registration fee is € 500 for clinicians and scientists; special fees might apply to (members of) companies. Please send your inquiries to: [email protected] or book your spot through the Book now button on top of this page. 

The total number of delegates is limited to max. 120 persons. Restrictions due to COVID may apply. 

 


The Organisers

Thierry Burnouf

Thierry Burnouf

Global Blood Safety Working Party Secretary, Cellular Therapies Steering Committee member, Vice-Dean, Taipei Medical University, Taiwan

Christian Gabriel

Christian Gabriel

Cellular Therapies Working Party Steering Committee member, Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Vienna, Austria

Reinhard Henschler

Reinhard Henschler

Cellular Therapies Working Party Steering Committee member, Director, Institute of Transfusion Medicine bei University Hospital Leipzig, Germany

Jutta Horwath-Winter
Mickey Koh

Mickey Koh

Cellular Therapies Working Party Chair, Director, Stem Cell Transplantation at St George's hospital and Medical School, London, UK

Denese Marks

Denese Marks

ISBT Regional Director Western Pacific, ISBT BC WP Chair, Associate Professor, University of Sydney, Australia; Australian Red Cross LifeBlood Service

Katharina Schallmoser

Katharina Schallmoser

Paracelsus Medical University Salzburg, Austria


Any questions? Contact us at [email protected]